The promising preclinical results have now paved the way for evaluating the use of GLP-1R agonists in clinical studies with neurodegenerative diseases such as Alzheimers disease , Parkinsons disease , stroke , and diabetic neuropathy
Following withdrawal, GLP-1 is implicated in neural repair processes within the central nervous system, leading to an upregulation of c-Fos expression in glutamatergic neurons located in the BLA
If you have diabetes, do not discontinue GLP-1 medication without a comprehensive plan from your endocrinologist or diabetes care team
In this case, you can consult your healthcare provider and may consider changing treatment plans
Context & Purpose These Dietary Guidelines for Americans are updated every five years and influence federal nutrition programs (e.g., school meals, SNAP)